<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Many antiviral compounds have been developed against the influenza virus, the long-term efficacy of which is often limited due to toxicity or the emergence of drug-resistant virus mutants [
 <xref rid="b14-ophrp-09-348" ref-type="bibr" class="xref">14</xref>]. Hence, new approaches for the control of highly pathogenic influenza viruses must be explored.
</p>
